157 related articles for article (PubMed ID: 8027975)
1. Organometallic anticancer agents: the effect of the central metal and halide ligands on the interaction of metallocene dihalides Cp2MX2 with nucleic acid constituents.
Murray JH; Harding MM
J Med Chem; 1994 Jun; 37(13):1936-41. PubMed ID: 8027975
[TBL] [Abstract][Full Text] [Related]
2. A (1)H NMR study of the interaction of antitumor metallocenes with glutathione.
Mokdsi G; Harding MM
J Inorg Biochem; 2001 Sep; 86(2-3):611-6. PubMed ID: 11566334
[TBL] [Abstract][Full Text] [Related]
3. Organometallic anticancer agents. 2. Aqueous chemistry and interaction of niobocene dichloride with nucleic acid constituents and amino acids.
Harding MM; Prodigalidad M; Lynch MJ
J Med Chem; 1996 Dec; 39(25):5012-6. PubMed ID: 8960562
[TBL] [Abstract][Full Text] [Related]
4. Antitumour metallocenes: structure-activity studies and interactions with biomolecules.
Harding MM; Mokdsi G
Curr Med Chem; 2000 Dec; 7(12):1289-303. PubMed ID: 11032972
[TBL] [Abstract][Full Text] [Related]
5. Titanium(IV) targets phosphoesters on nucleotides: implications for the mechanism of action of the anticancer drug titanocene dichloride.
Guo M; Guo Z; Sadler PJ
J Biol Inorg Chem; 2001 Sep; 6(7):698-707. PubMed ID: 11681703
[TBL] [Abstract][Full Text] [Related]
6. A molecular docking study of the interactions between human transferrin and seven metallocene dichlorides.
Güette-Fernández JR; Meléndez E; Maldonado-Rojas W; Ortega-Zúñiga C; Olivero-Verbel J; Parés-Matos EI
J Mol Graph Model; 2017 Aug; 75():250-265. PubMed ID: 28609757
[TBL] [Abstract][Full Text] [Related]
7. Binding and hydrolysis studies of antitumoural titanocene dichloride and Titanocene Y with phosphate diesters.
Erxleben A; Claffey J; Tacke M
J Inorg Biochem; 2010 Apr; 104(4):390-6. PubMed ID: 20036426
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of bent metallocenes: electronic structure analysis using DFT computations.
Senthilnathan D; Vaideeswaran S; Venuvanalingam P; Frenking G
J Mol Model; 2011 Mar; 17(3):465-75. PubMed ID: 20495841
[TBL] [Abstract][Full Text] [Related]
9. Coordination chemistry of the antitumor metallocene molybdocene dichloride with biological ligands.
Waern JB; Harding MM
Inorg Chem; 2004 Jan; 43(1):206-13. PubMed ID: 14704069
[TBL] [Abstract][Full Text] [Related]
10. A 31P NMR study of the interaction of the antitumor active metallocene Cp2MoCl2 with calf thymus DNA.
Harding MM; Harden GJ; Field LD
FEBS Lett; 1993 May; 322(3):291-4. PubMed ID: 8486161
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human topoisomerase II by the antitumor metallocenes.
Mokdsi G; Harding MM
J Inorg Biochem; 2001 Jan; 83(2-3):205-9. PubMed ID: 11237260
[TBL] [Abstract][Full Text] [Related]
12. Inclusion complexes of the antitumour metallocenes Cp(2)MCl(2) (M = Mo, Ti) with cucurbit[n]urils.
Buck DP; Abeysinghe PM; Cullinane C; Day AI; Collins JG; Harding MM
Dalton Trans; 2008 May; (17):2328-34. PubMed ID: 18414758
[TBL] [Abstract][Full Text] [Related]
13. Bifunctional antitumor compounds: interaction of adriamycin with metallocene dichlorides.
Moustatih A; Fiallo MM; Garnier-Suillerot A
J Med Chem; 1989 Feb; 32(2):336-42. PubMed ID: 2536437
[TBL] [Abstract][Full Text] [Related]
14. Intracellular mapping of the distribution of metals derived from the antitumor metallocenes.
Waern JB; Harris HH; Lai B; Cai Z; Harding MM; Dillon CT
J Biol Inorg Chem; 2005 Aug; 10(5):443-52. PubMed ID: 15906108
[TBL] [Abstract][Full Text] [Related]
15. Organometallic anticancer agents: cellular uptake and cytotoxicity studies on thiol derivatives of the antitumor agent molybdocene dichloride.
Waern JB; Dillon CT; Harding MM
J Med Chem; 2005 Mar; 48(6):2093-9. PubMed ID: 15771451
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
Peri D; Meker S; Shavit M; Tshuva EY
Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
[TBL] [Abstract][Full Text] [Related]
17. Enhanced antitumour activity of cyclopendadienyl-substituted metallocene dihalides in human breast and colon cancer cells.
Stachtea X; Karamanos N; Klouras N
Anticancer Res; 2009 Aug; 29(8):3227-31. PubMed ID: 19661339
[TBL] [Abstract][Full Text] [Related]
18. Specific Interactions of Antitumor Metallocenes with Deoxydinucleoside Monophosphates.
Eberle RP; Hari Y; Schürch S
J Am Soc Mass Spectrom; 2017 Sep; 28(9):1901-1909. PubMed ID: 28500584
[TBL] [Abstract][Full Text] [Related]
19. Novel binding interactions of the DNA fragment d(pGpG) cross-linked by the antitumor active compound tetrakis(mu-carboxylato)dirhodium(II,II).
Chifotides HT; Koshlap KM; Pérez LM; Dunbar KR
J Am Chem Soc; 2003 Sep; 125(35):10714-24. PubMed ID: 12940757
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity studies of Ti(IV) complexes: aqueous stability and cytotoxic properties in colon cancer HT-29 cells.
Hernández R; Lamboy J; Gao LM; Matta J; Román FR; Meléndez E
J Biol Inorg Chem; 2008 Jun; 13(5):685-92. PubMed ID: 18288505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
